Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · S

S. 2912 (114th)

Trickett Wendler Right to Try Act of 2016

openUnited States· United States Congress· EN

Introduced

10 May 2016

Last action

22 September 2016 · Committee

Status

Committee on Homeland Security and Governmental Affairs. Hearings held.

Sponsors

Sen. Johnson, Ron [R-WI], Sen. Murkowski, Lisa [R-AK], Sen. Perdue, David [R-GA], Sen. Hatch, Orrin G. [R-UT], Sen. Blunt, Roy [R-MO], Sen. Flake, Jeff [R-AZ], Sen. Isakson, Johnny [R-GA], Sen. Inhofe, James M. [R-OK], Sen. McCain, John [R-AZ], Sen. Tillis, Thomas [R-NC], Sen. Graham, Lindsey [R-SC], Sen. Grassley, Chuck [R-IA], Sen. Rubio, Marco [R-FL], Sen. Sessions, Jeff [R-AL], Sen. Capito, Shelley Moore [R-WV], Sen. Corker, Bob [R-TN], Sen. Cotton, Tom [R-AR], Sen. Risch, James E. [R-ID], Sen. Boozman, John [R-AR], Sen. Vitter, David [R-LA], Sen. Toomey, Patrick [R-PA], Sen. Coats, Daniel [R-IN], Sen. Barrasso, John [R-WY], Sen. Sullivan, Dan [R-AK], Sen. Cruz, Ted [R-TX], Sen. Enzi, Michael B. [R-WY], Sen. Wicker, Roger F. [R-MS], Sen. Daines, Steve [R-MT], Sen. Crapo, Mike [R-ID], Sen. Lankford, James [R-OK], Sen. Manchin, Joe, III [D-WV], Sen. Roberts, Pat [R-KS], Sen. Hoeven, John [R-ND], Sen. Shelby, Richard C. [R-AL], Sen. Heller, Dean [R-NV], Sen. McConnell, Mitch [R-KY], Sen. Moran, Jerry [R-KS], Sen. Rounds, Mike [R-SD], Sen. Cochran, Thad [R-MS], Sen. Donnelly, Joe [D-IN], Sen. Gardner, Cory [R-CO], Sen. Paul, Rand [R-KY], Sen. Sasse, Ben [R-NE], Sen. King, Angus S., Jr. [I-ME]

Subjects

Healthcare

Source updated

12 August 2025

Healthcare

Summary

Trickett Wendler Right to Try Act of 2016 This bill bars the federal government from prohibiting or restricting the production, manufacture, distribution, prescribing, or dispensing of an experimental drug, biological product, or device that is: (1) intended to treat a patient who has been diagnosed with a terminal illness; and (2) authorized by, and in accordance with, state law. The federal government may not restrict the possession or use of such a treatment by a patient certified by a physician as having exhausted all other treatment options. A producer, manufacturer, distributor, prescriber, dispenser, possessor, or user of such a treatment has no liability regarding the treatment. The outcome of production, manufacture, distribution, prescribing, dispensing, possession, or use of such a treatment may not be used by a federal agency to adversely impact review or approval of the treatment. The treatment must: (1) have successfully completed a phase 1 (initial, small scale) clinical trial; (2) remain under investigation in a clinical trial approved by the Food and Drug Administration (FDA); and (3) not be approved, licensed, or cleared for sale under the Federal Food, Drug, or Cosmetic Act or the Public Health Service Act. Not later than 30 days after enactment of this bill, and every 30 days thereafter until implementation is complete, the FDA must report on its progress in implementing a streamlined application process for compassionate use of experimental drugs and biological products.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 10 May 2016

    Introduced

    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

    Source: IntroReferral

  2. 10 May 2016

    Introduced

    Introduced in Senate

    Source: IntroReferral

  3. 22 September 2016

    Committee

    Committee on Homeland Security and Governmental Affairs. Hearings held.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in Senate (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in Senate (text)

    Introduced in Senate · EN · 10 May 2016

    ViewDownloadOpen at official source

  • Introduced in Senate (PDF)

    Introduced in Senate · EN · 10 May 2016

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in Senate

    summary · EN · 10 May 2016

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.